Dr Greg Forlenza is an Associate Professor and Endocrinologist at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus. His clinical and research work focuses on type 1 diabetes and diabetes technology, including insulin pumps, continuous glucose monitoring and automated insulin delivery systems. With more than 15 years experience caring for children and young people with type 1 diabetes, Dr Forlenza is recognised for advancing and evaluating new diabetes technologies. His research explores the feasibility and real-world application of automated insulin delivery systems, with the goal of improving health outcomes and reducing the daily burden of diabetes management for children, young people and their families. His research has been supported by leading organisations including the National Institutes of Health, Breakthrough T1D, the Leona M. and Harry B. Helmsley Charitable Trust and the National Science Foundation. His current work includes next-generation automated insulin delivery systems designed to make diabetes care safer, more personalised and less demanding."